X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2683) 2683
Book Review (519) 519
Publication (201) 201
Book Chapter (65) 65
Conference Proceeding (17) 17
Dissertation (16) 16
Magazine Article (4) 4
Web Resource (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hyperphosphatemia (1892) 1892
index medicus (1869) 1869
humans (1770) 1770
male (997) 997
urology & nephrology (992) 992
female (889) 889
middle aged (653) 653
aged (518) 518
hemodialysis-patients (447) 447
calcium (442) 442
hyperphosphatemia - etiology (439) 439
hemodialysis (436) 436
adult (425) 425
chronic kidney-disease (422) 422
hyperphosphatemia - drug therapy (404) 404
phosphates - blood (397) 397
phosphorus (397) 397
renal dialysis (377) 377
animals (375) 375
mortality (368) 368
phosphate (365) 365
chronic kidney disease (350) 350
phosphates (330) 330
sevelamer (321) 321
kidney failure, chronic - therapy (310) 310
nephrology (309) 309
kidney failure, chronic - complications (295) 295
phosphorus - blood (294) 294
dialysis (291) 291
calcification (285) 285
stage renal-disease (270) 270
vascular calcification (263) 263
dialysis patients (261) 261
risk factors (250) 250
treatment outcome (250) 250
hyperphosphatemia - blood (247) 247
phosphates - metabolism (246) 246
calcium - blood (238) 238
parathyroid-hormone (238) 238
chelating agents - therapeutic use (234) 234
secondary hyperparathyroidism (234) 234
parathyroid hormone (220) 220
phosphate binder (220) 220
parathyroid hormone - blood (213) 213
lanthanum carbonate (203) 203
mineral metabolism (200) 200
phosphate binders (199) 199
chronic-renal-failure (195) 195
kidney diseases (191) 191
hypocalcemia (188) 188
chronic kidney failure (185) 185
serum phosphorus (185) 185
hyperparathyroidism (175) 175
renal dialysis - adverse effects (170) 170
hyperphosphatemia - complications (165) 165
renal insufficiency, chronic - complications (163) 163
vitamin d (163) 163
kidney failure, chronic - blood (160) 160
disease (149) 149
sevelamer hydrochloride (149) 149
time factors (148) 148
polyamines - therapeutic use (147) 147
hypercalcemia (146) 146
medicine & public health (146) 146
endocrinology & metabolism (145) 145
coronary-artery calcification (142) 142
rats (142) 142
medicine, general & internal (139) 139
aged, 80 and over (138) 138
hyperphosphatemia - metabolism (137) 137
pharmacology & pharmacy (137) 137
hyperphosphatemia - prevention & control (136) 136
lanthanum - therapeutic use (136) 136
transplantation (133) 133
calcium carbonate (132) 132
mortality risk (131) 131
prospective studies (129) 129
metabolism (126) 126
fgf23 (122) 122
care and treatment (120) 120
hypophosphatemia (118) 118
biomarkers - blood (116) 116
retrospective studies (116) 116
pediatrics (115) 115
analysis (114) 114
phosphates - adverse effects (113) 113
calcium-carbonate (112) 112
mice (112) 112
administration, oral (111) 111
cardiovascular-disease (111) 111
child (111) 111
association (109) 109
homeostasis (107) 107
hyperphosphatemia - diagnosis (107) 107
maintenance hemodialysis (105) 105
adolescent (104) 104
diet (104) 104
hematology (104) 104
hyperphosphatemia - therapy (104) 104
abridged index medicus (103) 103
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2373) 2373
Spanish (92) 92
German (78) 78
French (53) 53
Japanese (53) 53
Italian (19) 19
Russian (19) 19
Korean (18) 18
Polish (13) 13
Portuguese (10) 10
Chinese (7) 7
Czech (4) 4
Danish (3) 3
Turkish (3) 3
Croatian (2) 2
Estonian (1) 1
Finnish (1) 1
Hungarian (1) 1
Indonesian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2016, Volume 31, Issue 10, pp. 1845 - 1854
Journal Article
Kidney International, ISSN 0085-2538, 06/2011, Volume 79, Issue 12, pp. 1370 - 1378
Journal Article
Kidney International, ISSN 0085-2538, 11/2013, Volume 84, Issue 5, pp. 998 - 1008
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 12/2017, Volume 118, Issue 12, pp. 4708 - 4715
Activation of Nrf2‐ARE signaling pathway may prevent hyperphosphatemia‐induced VC by inducing autophagy in VSMCs. 
AUTOPHAGY | HYPERPHOSPHATEMIA‐INDUCED VASCULAR CALCIFICATION | VASCULAR SMOOTH MUSCLE CELL | Nrf2‐ARE SIGNALING PATHWAY | Nrf2-ARE SIGNALING PATHWAY | HYPERPHOSPHATEMIA-INDUCED VASCULAR CALCIFICATION | OXIDATIVE STRESS | MANAGEMENT | INFLAMMATORY DISEASES | BIOCHEMISTRY & MOLECULAR BIOLOGY | SERUM PHOSPHORUS | RUNX2 | CELL BIOLOGY | IN-VITRO | GAMMA-GLUTAMYLCYSTEINE SYNTHETASE | HEMODIALYSIS | CHRONIC KIDNEY-DISEASE | EXPRESSION | Kidney - blood supply | Kidney - pathology | Muscle, Smooth, Vascular - metabolism | Response Elements | Signal Transduction | Myocytes, Smooth Muscle - pathology | Hyperphosphatemia - metabolism | Rats | Vascular Calcification - prevention & control | Male | Vascular Calcification - pathology | Autophagy | Rats, Sprague-Dawley | Hyperphosphatemia - pathology | Vascular Calcification - metabolism | Kidney - metabolism | Muscle, Smooth, Vascular - pathology | Animals | Hyperphosphatemia - prevention & control | NF-E2-Related Factor 2 - metabolism | Myocytes, Smooth Muscle - metabolism | Prevention | Calcification | Smooth muscle | Bone morphogenetic proteins | Phosphorus imbalance | Transmission electron microscopes | Calcification (ectopic) | Cbfa-1 protein | Ion concentration | Kidneys | Bone morphogenetic protein 2 | Calcium | Genes | Phagosomes | Phosphorus | Activation | siRNA | Western blotting | Polymerase chain reaction | Antioxidants | Signal transduction | Biomedical materials | Hyperphosphatemia | Biocompatibility | Phagocytosis | Apoptosis | Index Medicus
Journal Article
Journal Article
Clinical and Experimental Nephrology, ISSN 1342-1751, 06/2017, Volume 21, Issue 3, pp. 523 - 523
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10157-016-1350-0 
Hyperphosphatemia | Hemodialysis
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 02/2015, Volume 26, Issue 2, pp. 493 - 503
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 09/2017, Volume 12, Issue 9, pp. 1489 - 1497
Background and objectives Prior studies have shown that sevelamer attenuates progression of arterial calcification and may reduce the risk of death compared... 
CORONARY-ARTERY CALCIFICATION | SERUM PHOSPHATE | PROPENSITY SCORE | NUTRITIONAL-STATUS | DIALYSIS OUTCOMES | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | DOPPS | PRACTICE PATTERNS | CKD | HYDROCHLORIDE | Prospective Studies | Hyperphosphatemia - mortality | Humans | Middle Aged | Male | Practice Patterns, Physicians | North America | Sevelamer - therapeutic use | Hyperphosphatemia - blood | Renal Insufficiency, Chronic - therapy | Kidney - metabolism | Renal Dialysis - mortality | Time Factors | Phosphates - blood | Renal Insufficiency, Chronic - mortality | Female | Drug Therapy, Combination | Sevelamer - adverse effects | Chelating Agents - therapeutic use | Kidney - physiopathology | Chelating Agents - adverse effects | Kidney - drug effects | Europe | Risk Factors | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Renal Insufficiency, Chronic - physiopathology | New Zealand | Renal Insufficiency, Chronic - blood | Propensity Score | Renal Dialysis - adverse effects | Hyperphosphatemia - drug therapy | Aged | Australia | Drug Substitution | Hyperphosphatemia - physiopathology | Health Care Surveys | Index Medicus | Fluid Therapy | Confidence Intervals | Calcium, Dietary | Dialysis Outcomes and Practice Patterns Study (DOPPS): hemodialysis | survival | sevelamer | Phosphorus | Calcium Phosphates | hyperphosphatemia | calcium phosphate | Original | renal dialysis
Journal Article
13.